Flora Growth Corp. (NASDAQ:FLGC – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 901,000 shares, a growth of 325.0% from the October 15th total of 212,000 shares. Based on an average daily volume of 293,400 shares, the short-interest ratio is currently 3.1 days. Currently, 9.7% of the shares of the company are short sold.
Analyst Ratings Changes
Separately, Alliance Global Partners reiterated a “neutral” rating on shares of Flora Growth in a research note on Thursday, August 15th.
Check Out Our Latest Stock Report on FLGC
Flora Growth Stock Down 4.2 %
Flora Growth (NASDAQ:FLGC – Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.17). Flora Growth had a negative net margin of 21.56% and a negative return on equity of 161.06%. The firm had revenue of $15.68 million for the quarter, compared to the consensus estimate of $20.74 million. Analysts forecast that Flora Growth will post -0.48 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Flora Growth
An institutional investor recently raised its position in Flora Growth stock. Renaissance Technologies LLC boosted its position in shares of Flora Growth Corp. (NASDAQ:FLGC – Free Report) by 105.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 159,595 shares of the company’s stock after acquiring an additional 81,982 shares during the period. Renaissance Technologies LLC owned approximately 1.19% of Flora Growth worth $163,000 at the end of the most recent quarter. Institutional investors own 36.01% of the company’s stock.
Flora Growth Company Profile
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
See Also
- Five stocks we like better than Flora Growth
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Rocket Lab is the Right Stock for the Right Time
- Bank Stocks – Best Bank Stocks to Invest In
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Conference Calls and Individual Investors
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.